Cargando…
Novel Erlotinib–Chalcone Hybrids Diminish Resistance in Head and Neck Cancer by Inducing Multiple Cell Death Mechanisms
In a search for novel therapeutic options for head and neck squamous cell carcinomas (HNSCCs) generally treated with limited therapeutic success, we synthesized a series of novel erlotinib–chalcone molecular hybrids with 1,2,3-triazole and alkyne linkers and evaluated them for their anticancer activ...
Autores principales: | Murányi, József, Duró, Cintia, Gurbi, Bianka, Móra, István, Varga, Attila, Németh, Krisztina, Simon, József, Csala, Miklós, Csámpai, Antal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964293/ https://www.ncbi.nlm.nih.gov/pubmed/36834866 http://dx.doi.org/10.3390/ijms24043456 |
Ejemplares similares
-
Synthesis and Antiproliferative Activity of Novel Imipridone–Ferrocene Hybrids with Triazole and Alkyne Linkers
por: Czuczi, Tamás, et al.
Publicado: (2022) -
Novel Crizotinib–GnRH Conjugates Revealed the Significance of Lysosomal Trapping in GnRH-Based Drug Delivery Systems
por: Murányi, József, et al.
Publicado: (2019) -
The Potential Impact of Connexin 43 Expression on Bcl-2 Protein Level and Taxane Sensitivity in Head and Neck Cancers–In Vitro Studies
por: Gurbi, Bianka, et al.
Publicado: (2019) -
Protein Kinase D3 (PKD3) Requires Hsp90 for Stability and Promotion of Prostate Cancer Cell Migration
por: Varga, Attila, et al.
Publicado: (2023) -
MEK Is a Potential Indirect Target in Subtypes of Head and Neck Cancers
por: Gurbi, Bianka, et al.
Publicado: (2023)